Conference scene: Highlights of the 7th Autoimmunity Congress.
This meeting was dedicated to various autoimmune diseases and their mechanisms, diagnosis and therapies. The autoimmunity-promoting factors included genetic variations and environmental injuries. A broad array of cytokines, including the B-cell activating factor, and autoantibodies, including novel specificities, were discussed. Finally, new horizons in treatment, including tolerogenic peptides, intravenous immunoglobulin and B-cell-depleting agents, were presented.
Youinou
Pierre
P
D000818:Animals; D001323:Autoantibodies / Q000276:immunology*; D001327:Autoimmune Diseases / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D015551:Autoimmunity; D053264:B-Cell Activating Factor / Q000276:immunology; D018604:Epitope Mapping; D020022:Genetic Predisposition to Disease; D006801:Humans; D007108:Immune Tolerance; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D008212:Lymphocyte Depletion; D022223:Vaccines, Subunit / Q000627:therapeutic use*
D001323:Autoantibodies; D053264:B-Cell Activating Factor; D016756:Immunoglobulins, Intravenous; D022223:Vaccines, Subunit